Genistein elicits biphasic effects on L-type Ca2+ current in feline atrial myocytes

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 275, Issue 1 44-1, 1998, Pages

  Wang, Yong G ^a   Lipsius, Stephen L ^a,b  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cardiac; Daidzein; Electrophysiology; Perforated patch; Vanadate

Indexed keywords

ADENOSINE 3',5' PHOSPHOROTHIOATE; CALCIUM ION; CALPHOSTIN C; CYCLIC AMP DEPENDENT PROTEIN KINASE; DAIDZEIN; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GENISTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RYANODINE; VANADIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CAT; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG EFFECT; HEART ATRIUM; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 33750860208     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.275.1.h204     Document Type: Article

References (40)

1. Akiyama, T., J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595, 1987.
2. 3 cells. J. Biol. Chem. 271: 9441-9446, 1996.
3. Chabre, M. Aluminofluoride and beryllofluoride complexes: new phosphate analogs in enzymology. Trends Biochem. Sci. 15: 6-10, 1990.
4. Chiang, C., S. Chen, M. Chang, C. Cheng, and H. Luk. Genistein directly inhibits L-type calcium currents but potentiates cAMP-dependent chloride current in cardiomyocytes. Biochem. Biophys. Res. Commun. 223: 598-603, 1996.
5. Chijiwa, T., A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T. Toshioka, and H. Hidaka. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265: 5267-5272, 1990.
6. Dostmann, W. R., S. S. Taylor, H.-G. Genieser, B. Jastorff, S. O. Doskeland, and D. Ogreid. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinase I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates. J. Biol. Chem. 265: 10484-10491, 1990.
7. DuBell, W. H., B. Lewartowski, H. A. Spurgeon, H. S. Silverman, and E. G. Lakatta. Repletion of sarcoplasmic reticulum Ca after ryanodine in rat ventricular myocytes. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H604-H615, 1993.
8. 2+/calmodulin-dependent protein kinase isoforms. Biochim. Biophys. Acta 1221: 89-101, 1994.
9. Erpel, T., and S. A. Courtneidge. Src family protein tyrosine kinases and cellular signaling transduction pathways. Curr. Opin. Cell Biol. 7: 176-182, 1995.
10. Gordon, J. A. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201: 477-482, 1991.
11. 2+ mobilization in swine carotid media. Am. J. Physiol. 268 (Cell Physiol. 37): C1425-C1429, 1995.
12. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100, 1981.
13. Herbert, J. M., J. M. Augereau, J. Gleye, and J. P. Maffrand. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 172: 993-999, 1990.
14. Horn, R., and A. Marty. Muscarinic activation of ionic currents measured by a new whole cell recording method. J. Gen. Physiol. 92: 145-159, 1988.
15. Huang, X., A. D. Morielli, and E. G. Peralta. Tyrosine kinase-dependent suppression of a potassium channel by the G protein-coupled m1 muscarinic acetylcholine receptor. Cell 75: 1145-1156, 1997.
16. Ihle, J. N., and I. M. Kerr. Jaks and Stats in signaling by the cytokine receptor superfamily. TIG 11: 69-73, 1995.
17. Kirstein, M., M. Rivet-Bastide, S. Hatem, A. Benardeau, J.-J. Mercadier, and R. Fischmeister. Nitric oxide regulates the calcium current in isolated human atrial myocytes. J. Clin. Invest. 95: 794-802, 1995.
18. Knowles, R. G., and S. Moncada. Nitric oxide synthase in mammals. Biochem. J. 298: 249-258, 1994.
19. Kobayashi, E., H. Nakano, M. Morimoto, and T. Tamaoki. Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159: 548-553, 1989.
20. Kusaka, M., and N. Sperelakis. Inhibition of L-type calcium current by genistein, a tyrosine kinase inhibitor, in pregnant rat myometrial cells. Biochim. Biophys. Acta 1240: 196-200, 1995.
21. 2+-induced regulation of ion channel and MAP kinase functions. Nature 376: 737-745, 1995.
22. Paillart, C., E. Carlier, D. Guedin, B. Dargent, and F. Courand. Direct block of voltage-sensitive sodium channels by genistein, a tyrosine kinase inhibitor. J. Pharmacol. Exp. Ther. 280: 521-526, 1997.
23. Schatzmann, H. J., S. Luterbacher, J. Stieger, and A. Wuthrich. Red blood cell calcium pump and its inhibition by vanadate and lanthanum. J. Cardiovasc. Pharmacol. 8, Suppl.: S33-S37, 1986.
24. Semenchuk, L. A., and J. Di Salvo. Receptor-activated increases in intracellular calcium and protein tyrosine phosphorylation in vascular smooth muscle cells. FEBS Lett. 370: 127-130, 1995.
25. Sharma, N. R., and M. J. Davis. Calcium entry activated by store depletion in coronary endothelium is promoted by tyrosine phosphorylation. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H267-H274, 1996.
26. Shirayama, T., and A. J. Pappano. Diphasic effects of intrapipette cyclic guanosine monophosphate on L-type calcium current and contraction of guinea pig ventricular myocytes. J. Pharmacol. Exp. Ther. 279: 1274-1281, 1996.
27. Shuba, L. M., T. Asai, S. Pelzer, and T. F. McDonald. Activation of cardiac chloride conductance by the tyrosine kinase inhibitor, genistein. Br. J. Pharmacol. 119: 335-345, 1996.
28. Siegelbaum, S. A. Ion channel control by tyrosine phosphorylation. Curr. Biol. 4: 242-245, 1994.
29. + currents by tyrosine kinase inhibitors genistein and ST 638. Circ. Res. 76: 310-316, 1995.
30. Sorota, S. Tyrosine protein kinase inhibitors prevent activation of cardiac swelling-induced chloride current. Pflügers Arch. 431: 178-185, 1995.
31. 2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation. Arch. Biochem. Biophys. 320: 236-242, 1995.
32. Tsiani, E., and I. G. Fantus. Vanadium compounds. Biological actions and potential as pharmacological agents. Trends Endocrinol. Metab. 8: 51-58, 1997.
33. Van der Geer, P., T. Hunter, and R. A. Lindberg. Receptor protein-tyrosine kinases and their signal transduction pathways. Annu. Rev. Cell Biol. 10: 251-337, 1994.
34. Wallace, B. G. Regulation of the interaction of nicotinic acetylcholine receptors with the cytoskeleton by agrin-activated protein tyrosine kinase. J. Cell Biol. 128: 1121-1129, 1995.
35. 2+ current mediated by pertussis toxin-sensitive G protein and cAMP-dependent protein kinase A in atrial myocytes. Circ. Res. 76: 634-644, 1995.
36. + current in cat atrial myocytes. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H1322-H1334, 1995.
37. 2+ current in cat atrial myocytes (Abstract). Biophys. J. 72: 110, 1997.
38. 2+ current elicited by withdrawal of acetylcholine in cat atrial myocytes. J. Gen. Physiol. 111: 113-125, 1998.
39. Wijetunge, S., C. Aalkjaer, M. Schachter, and A. D. Hughes. Tyrosine kinase inhibitors block calcium channel currents in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 189: 1620-1623, 1992.
40. Yokoshiki, H., K. Sumii, and N. Sperelakis. Inhibition of L-type calcium current in rat ventricular cells by the tyrosine kinase inhibitor, genistein and its inactive analog, daidzein. J. Mol. Cell. Cardiol. 28: 807-814, 1996.